Viral load in congenital cytomegalovirus infection

Herpes

Volumn 14, Issue 1, 2007, Pages 17-22

  Arav Boger, Ravit ^a   Pass, Robert ^b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b CHILDREN S HOSPITAL OF ALABAMA   (United States)

Author keywords

Congenital infection; Cytomegalovirus; Immunocompromised hosts; Pregnancy; Real time polymerase chain reaction; Viral load

Indexed keywords

ANTIVIRUS AGENT; GANCICLOVIR; VALGANCICLOVIR;

ANTIGEN DETECTION; ANTIVIRAL THERAPY; ARTICLE; CLINICAL TRIAL; CONGENITAL INFECTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GENE AMPLIFICATION; HEARING LOSS; HUMAN; NEUTROPENIA; NUCLEIC ACID ANALYSIS; PRENATAL SCREENING; PRIORITY JOURNAL; TREATMENT PLANNING; VIRUS LOAD;

CYTOMEGALOVIRUS INFECTIONS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; ORGAN TRANSPLANTATION; VIRAL LOAD;

CYTOMEGALOVIRUS;

EID: 34547799573     PISSN: 09697667     EISSN: 14701537     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Staras SA, Dollard SC, Radford KW, Flanders WD, Pass RF, Cannon MJ. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006;43:1143-1151.
2. Yow MD, Demmler GJ. Congenital cytomegalovirus disease - 20 years is long enough. N Engl J Med 1992;326:702-703.
3. Demmler GJ. Infectious Diseases Society of America and Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991;13:315-329.
4. Stagno S. In: Infectious Disease of the Fetus And Newborn Infant (Remington JS, Klein JO, eds). Philadelphia: Saunders WB, 1995;pp312-353.
5. Kimberlin DW, Lin CY, Sanchez PJ, Demmler GJ, Dankner W, Shelton M et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr 2003;143:16-25.
6. van der Bij W, van Son WJ, van der Berg AP, Tegzess AM, Torensma R, The TH. Cytomegalovirus (CMV) antigenemia: rapid diagnosis and relationship with CMV-associated clinical syndromes in renal allograft recipients. Transplant Proc 1989;21:2061-2064.
7. Tanabe K, Tokumoto T, Ishikawa N, Koyama I, Takahasbi K, Fuchinoue S et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 1997;64:1721-1725.
8. Gerna G, Percivalle E, Baldanti F, Sozzani S, Lanzarini P, Genini E et al. Human cytomegalovirus replicates abortively in polymorphonuclear leukocytes after transfer from infected endothelial cells via transient microfusion events. J Virol 2000;74:5629-5638.
9. Nichols WG, Corey L, Gooley T, Drew WL, Miner R, Huang M et al. Rising pp65 antigenemia during preemptive anticytomegalovirus therapy after allogeneic hematopoietic stem cell transplantation: risk factors, correlation with DNA load, and outcomes. Blood 2001;97:867-874.
10. Gerna G, Percivalle E, Torsellini M, Revello MG. Standardization of the human cytomegalovirus antigenemia assay by means of in vitro-generated pp65-positive peripheral blood polymorphonuclear leukocytes. J Clin Microbiol 1998;36:3585-3589.
11. Halwachs G, Zach R, Pogglitsch H, Holzer H, Tiran A, Iberer F et al. A rapid immunocytochemical assay for CMV detection in peripheral blood of organ-transplanted patients in clinical practice. Transplantation 1993;56:338-342.
12. Locatelli F, Percivalle E, Comoli P, Maccario R, Zecca M, Giorgiani G et al. Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenemia on patients' outcome. Br J Haematol 1994;88:64-71.
13. Mengelle C, Pasquier C, Rostaing L, Sandres-Saune K, Puel J, Berges L et al. Quantitation of human cytomegalovirus in recipients of solid organ transplants by real-time quantitative PCR and pp65 antigenemia. J Med Virol 2003;69:225-231.
14. Hadaya K, Wunderli W, Deffernez C, Martin PY, Mentha G, Binet I et al. Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay. J Clin Microbiol 2003;41:3757-3764.
15. Hernando S, Folgueira L, Lumbreras C, San Juan R, Maldonado S, Prieto C et al. Comparison of cytomegalovirus viral load measure by real-time PCR with pp65 antigenemia for the diagnosis of cytomegalovirus disease in solid organ transplant patients. Transplant Proc 2005;37:4094-4096.
16. Lilleri D, Baldanti F, Gatti M, Rovida F, Dossena L, De Grazia S et al. Clinically-based determination of safe DNAemia cutoff levels for preemptive therapy or human cytomegalovirus infections in solid organ and hematopoietic stem cell transplant recipients. J Med Virol 2004;73:412-418.
17. Blok MJ, Goossens VJ, Vanherle SJ, Top B, Tacken N, Middeldorp JM et al. Diagnostic value of monitoring human cytomegalovirus late pp67 mRNA expression in renal-allograft recipients by nucleic acid sequence-based amplification. J Clin Microbiol 1998;36:1341-1346.
18. Mengoli C, Cusinato R, Biasolo MA, Cesaro S, Parolin C, Palu G. Assessment of CMV load in solid organ transplant recipients by pp65 antigenemia and real-time quantitative DNA PCR assay: correlation with pp67 RNA detection. J Med Virol 2004;74:78-84.
19. Einsele H, Steidle M, Vallbracht A, Saal JG, Ehninger G, Muller CA. Early occurrence of human cytomegalovirus infection after bone marrow transplantation as demonstrated by the polymerase chain reaction technique. Blood 1991;77:1104-1110.
20. Mattes FM, Hainsworth EG, Geretti AM, Nebbia G, Prentice G, Potter M et al. A randomized, controlled trial comparing ganciclovir to ganciclovir plus foscarnet (each at half dose) for preemptive therapy of cytomegalovirus infection in transplant recipients. J Infect Dis 2004;189:1355-1361.
21. Paya CV, Wilson JA, Espy MJ, Sia IG, DeBernardi MJ, Smith TF et al. Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. J Infect Dis 2002;185:854-860.
22. DiDomenico N, Link H, Knobel R, Caratsch T, Weschler W, Loewy ZG et al. COBAS AMPLICOR: fully automated RNA and DNA amplification and detection system for routine diagnostic PCR. Clin Chem 1996;42:1915-1923.
23. Long CM, Drew L, Miner R, Jekic-McMullen D, Impraim C, Kao SY. Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test. J Clin Microbiol 1998;36:2434-2438.
24. Schaade L, Kockelkorn P, Ritter K, Kleines M. Detection of cytomegalovirus DNA in human specimens by LightCycler PCR. J Clin Microbiol 2000;38:4006-1009.
25. Caliendo AM, Schuurman R, Yen-Lieberman B, Spector SA, Andersen J, Manjiry R et al. Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasma. J Clin Microbiol 2001;39:1334- 1338.
26. Heid CA, Stevens J, Livak KJ, Williams PM. Real time quantitative PCR. Genome Res 1996;6:986-994.
27. Jabs DA, Forman M, Enger C, Jackson JB. Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. J Clin Microbiol 1999;37:1431-1435.
28. Zipeto D, Morris S, Hong C, Dowling A, Wolitz R, Merigan TC et al. Human cytomegalovirus (CMV) DNA in plasma reflects quantity of CMV DNA present in leukocytes. J Clin Microbiol 1995;33:2607-2611.
29. Gerna G, Furione M, Baldanti F, Sarasini A. Comparative quantitation of human cytomegalovirus DNA in blood leukocytes and plasma of transplant and AIDS patients. J Clin Microbiol 1994;32:2709-2717.
30. Sanchez JL, Storch GA. Multiplex, quantitative, real-time PCR assay for cytomegalovirus and human DNA. J Clin Microbiol 2002;40:2381-2386.
31. Razonable RR, Brown RA, Wilson J, Groettum C, Kremers W, Espy M et al. The clinical use of various blood compartments for cytomegalovirus (CMV) DNA quantitation in transplant recipients with CMV disease. Transplantation 2002;73:968-973.
32. Tanaka Y, Kanda Y, Kami M, Mori S, Hamaki T, Kusumi E et al. Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after hematopoietic stem cell transplantation. Bone Marrow Transplant 2002;30:315-319.
33. Ikewaki J, Ohtsuka E, Satou T, Kawano R, Ogata M, Kikuchi H et al. Real-time PCR assays based on distinct genomic regions for cytomegalovirus reactivation following hematopoietic stem cell transplantation. Bone Marrow Transplant 2005;35:403-410.
34. Yun Z, Lewensohn-Fuchs I, Ljungman P, Vahlne A. Real-time monitoring of cytomegalovirus infections after stem cell transplantation using the TaqMan polymerase chain reaction assays. Transplantation 2000;69:1733- 1736.
35. Herrmann B, Larsson VC, Rubin CJ, Sund F, Eriksson BM, Arvidson J et al. Comparison of a duplex quantitative real-time PCR assay and the COBAS AMPLICOR CMV Monitor test for detection of cytomegalovirus. J Clin Microbiol 2004;42:1909-1914.
36. Pang XL, Chui L, Fenton J, LeBlanc B, Preiksaitis JK. Comparison of LightCycler-based PCR, COBAS AMPLICOR CMV monitor, and pp65 antigenemia assays for quantitative measurement of cytomegalovirus viral load in peripheral blood specimens from patients after solid organ transplantation. J Clin Microbiol 2003;41:3167-3174.
37. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodologic aspects and clinical applications. Clin Microbiol Rev 1998;11:533-554.
38. Sanchez JL, Kruger RM, Paranjothi S, Trulock EP, Lynch JP, Hicks C et al. Relationship of cytomegalovirus viral load in blood to pneumonitis in lung transplant recipients. Transplantation 2001;72:733-735.
39. Griscelli F, Barrois M, Chauvin S, Lastere S, Bellet D, Bourhis JH. Quantification of human cytomegalovirus DNA in bone marrow transplant recipients by real-time PCR. J Clin Microbiol 2001;39:4362-4369.
40. Machida U, Kami M, Fukui T, Kazuyama Y, Kinoshita M, Tanaka Y et al. Real-time automated PCR for early diagnosis and monitoring of cytomegalovirus infection after bone marrow transplantation. J Clin Microbiol 2000;38:2536-2542.
41. Paya CV. Prevention of cytomegalovirus disease in recipients of solid-organ transplants. Clin Infect Dis 2001;32:596-603.
42. Aitken C, Barrett-Muir W, Millar C, Templeton K, Thomas J, Sheridan F et al. Use of molecular assays in diagnosis and monitoring of cytomegalovirus disease following renal transplantation. J Clin Microbiol 1999;37:2804-2807.
43. Spector SA, Hsia K, Crager M, Pilcher M, Cabral S, Stempien MJ. Cytomegalovirus (CMV) DNA load is an independent predictor of CMV disease and survival in advanced AIDS. J Virol 1999;73:7027-7030.
44. Revello MG, Zavattoni M, Furione M, Baldanti F, Gerna G. Quantification of human cytomegalovirus DNA in amniotic fluid of mothers of congenitaily infected fetuses. J Clin Microbiol 1999;37:3350-3352.
45. Gouarin S, Gault E, Vabret A, Cointe D, Rozenberg F, Grangeot-Keros L et al. Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol 2002;40:1767-1772.
46. Picone O, Costa JM, Leruez-Ville M, Ernault P, Olivi M, Ville Y. Cytomegalovirus (CMV) glycoprotein B genotype and CMV DNA load in the amniotic fluid of infected fetuses. Prenat Diagn 2004;24:1001-1006.
47. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000;137:90-95.
48. Revello MG, Lilleri D, Zavattoni M, Furione M, Middeldorp J, Gerna G. Prenatal diagnosis of congenital human cytomegalovirus infection in amniotic fluid by nucleic acid sequence-based amplification assay. J Clin Microbiol 2003;41:1772-1774.
49. Revello MG, Zavattoni M, Baldanti F, Sarasini A, Paolucci S, Gerna G. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999;14:57-66.
50. Bradford RD, Cloud G, Lakeman AD, Boppana S, Kimberlin DW, Jacobs R et al. Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis 2005;191:227-233.
51. Lanari M, Lazzarotto T, Venturi V, Papa I, Gabrielli L, Guerra B et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006;117:e76-e83.
52. Boppana SB, Fowler KB, Pass RF, Rivera LB, Bradford RD, Lakeman FD et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005;146:817-823.
53. Halwachs-Baumann G, Genser B, Pailer S, Engele H, Rosegger H, Schalk A et al. Human cytomegalovirus load in various body fluids of congenitally infected newborns. J Clin Virol 2002;25:S81-S87.
54. Sugiura S, Yoshikawa T, Nishiyama Y, Morishita Y, Sato E, Beppu R et al. Detection of herpesvirus DNAs in perilymph obtained from patients with sensorineural hearing loss by real-time polymerase chain reaction. Laryngoscope 2004;114:2235-2238.
55. Tanaka-Kitajima N, Sugaya N, Futatani T, Kanegane H, Suzuki C, Oshiro M et al. Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 2005;24:782-785.